Phase I clinical trial of MDCO 216 in healthy volunteers and patients with coronary artery disease.

Trial Profile

Phase I clinical trial of MDCO 216 in healthy volunteers and patients with coronary artery disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 Aug 2016

At a glance

  • Drugs MDCO 216 (Primary)
  • Indications Coronary artery disease
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors The Medicines Company
  • Most Recent Events

    • 17 Feb 2016 According to The Medicines Company media release, the company has announced positive results.
    • 14 Dec 2015 Results published in The Medicine Company media release.
    • 14 Dec 2015 Results published in the European Heart Journal - Cardiovascular Pharmacology, according to The Medicines Company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top